WO2002100843A1 - Phenoxazine compounds, the compositions containing them and their medicinal uses - Google Patents

Phenoxazine compounds, the compositions containing them and their medicinal uses Download PDF

Info

Publication number
WO2002100843A1
WO2002100843A1 PCT/CN2001/000968 CN0100968W WO02100843A1 WO 2002100843 A1 WO2002100843 A1 WO 2002100843A1 CN 0100968 W CN0100968 W CN 0100968W WO 02100843 A1 WO02100843 A1 WO 02100843A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
compositions containing
phenoxazine compounds
medicinal uses
formulae
phenoxazine
Prior art date
Application number
PCT/CN2001/000968
Other languages
French (fr)
Inventor
Jianqing Lu
Original Assignee
Jianqing Lu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/38[b, e]-condensed with two six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings

Abstract

The invention relates to the phenoxazine compounds of formulae I, and the pharmaceutical acceptable salts, esters, amides and prodrugs thereof, to the pharmaceutical compositions containing them, to the use of the preparation of the medicines for inhibiting the starchy protein coagulate. The definitions of R1, R2 and R in formulae I are described in the specification.
PCT/CN2001/000968 2001-06-13 2001-06-13 Phenoxazine compounds, the compositions containing them and their medicinal uses WO2002100843A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000968 WO2002100843A1 (en) 2001-06-13 2001-06-13 Phenoxazine compounds, the compositions containing them and their medicinal uses

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2001/000968 WO2002100843A1 (en) 2001-06-13 2001-06-13 Phenoxazine compounds, the compositions containing them and their medicinal uses
CN 01801106 CN1366519A (en) 2001-06-13 2001-06-13 Phenoxazine compounds, its pharmaceutical compositions and medical use

Publications (1)

Publication Number Publication Date
WO2002100843A1 true true WO2002100843A1 (en) 2002-12-19

Family

ID=4574812

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000968 WO2002100843A1 (en) 2001-06-13 2001-06-13 Phenoxazine compounds, the compositions containing them and their medicinal uses

Country Status (2)

Country Link
CN (1) CN1366519A (en)
WO (1) WO2002100843A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118580A3 (en) * 2004-05-12 2006-08-03 John H Cardellina Tricyclic compounds as inhibitors of the hypoxic signaling pathway
GB2433071A (en) * 2005-12-05 2007-06-13 Kontrakt Technology Ltd Organic acids comprising planar conjugated heterocyclic molecular system, & photoelectric layer thereof with rodlike supramolecules for use in solar cell

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103819423B (en) * 2014-02-13 2015-04-15 江苏傲伦达科技实业股份有限公司 Method for synthesizing N-aryl-phenoxazine compounds

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0156347A2 (en) * 1984-03-29 1985-10-02 Boehringer Mannheim Gmbh Glycosides of resofurin derivatives, method for their preparation and their use in the determination of the activity of glycosidases
CN1086825A (en) * 1992-08-31 1994-05-18 弗·哈夫曼-拉罗切有限公司 The present invention is concerned with tri- and tetracyclic compounds
US5498542A (en) * 1994-09-29 1996-03-12 Bayer Corporation Electrode mediators for regeneration of NADH and NADPH

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0156347A2 (en) * 1984-03-29 1985-10-02 Boehringer Mannheim Gmbh Glycosides of resofurin derivatives, method for their preparation and their use in the determination of the activity of glycosidases
CN1086825A (en) * 1992-08-31 1994-05-18 弗·哈夫曼-拉罗切有限公司 The present invention is concerned with tri- and tetracyclic compounds
US5498542A (en) * 1994-09-29 1996-03-12 Bayer Corporation Electrode mediators for regeneration of NADH and NADPH

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118580A3 (en) * 2004-05-12 2006-08-03 John H Cardellina Tricyclic compounds as inhibitors of the hypoxic signaling pathway
GB2433071A (en) * 2005-12-05 2007-06-13 Kontrakt Technology Ltd Organic acids comprising planar conjugated heterocyclic molecular system, & photoelectric layer thereof with rodlike supramolecules for use in solar cell

Also Published As

Publication number Publication date Type
CN1366519A (en) 2002-08-28 application

Similar Documents

Publication Publication Date Title
CA2508024A1 (en) Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof
CA2361364A1 (en) Dalda analogs and their use
WO2006063841A3 (en) Trycyclic heterocycles, their manufacture and use as pharmaceutical agents
WO2004060882A8 (en) Cb 1/cb 2 receptor ligands and their use in the treatment of pain
WO2003051838A3 (en) Protein kinase inhibitors
WO2005056524A3 (en) Therapeutic agents useful for treating pain
WO2003051276B1 (en) Therapeutic heterocycles
CA2506290C (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
CA2400394A1 (en) 9-alkylamino-1-nitroacridine derivatives
WO2005005414A3 (en) Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2004098594A3 (en) Dosage form containing pantoprazole as active ingredient
CA2408323A1 (en) Drug delivery systems for photodynamic therapy
CA2496688A1 (en) Glycinamide derivatives as raf-kinase inhibitors

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP